Based on the well-known role of TGFβ in inducing collagens gene expression, other potential therapeutic targets that must be included in this section, as an extension of Proline metabolism targets for cancer treatment, are TGFβ inhibitors, which are the focus of many research projects and clinical trials (135). Here, TGFB1 is linked to cancer.